Check-Cap Ltd Net Assets

Latest as of December 2025: €3.44 Million EUR ≈ $4.02 Million USD

Check-Cap Ltd net assets. Based on the latest financial reports, Check-Cap Ltd (7CC) has net assets worth €3.44 Million EUR (≈ $4.02 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€7.49 Million ≈ $8.75 Million USD) and total liabilities (€4.05 Million ≈ $4.73 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 7CC shareholders equity momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets €3.44 Million
% of Total Assets 45.91%
Annual Growth Rate -11.58%
5-Year Change -93.22%
10-Year Change N/A
Growth Volatility 109.73

Net Assets of Check-Cap Ltd (2016–2025)

Net assets of Check-Cap Ltd from 2016 to 2025. This chart illustrates how Check-Cap Ltd's net assets have evolved over time, based on quarterly financial data. See Check-Cap Ltd balance sheet quality to measure how much of total assets are equity-financed.

Annual Net Assets for Check-Cap Ltd (2016–2025)

The table below shows the annual net assets of Check-Cap Ltd from 2016 to 2025. For live market cap and overall valuation, see 7CC market cap overview.

Year Net Assets Change
2025-12-31 €3.44 Million
≈ $4.02 Million
+337.03%
2024-12-31 €-1.45 Million
≈ $-1.70 Million
-106.12%
2023-12-31 €23.69 Million
≈ $27.69 Million
-42.66%
2022-12-31 €41.31 Million
≈ $48.30 Million
-18.50%
2021-12-31 €50.69 Million
≈ $59.26 Million
+209.51%
2020-12-31 €16.38 Million
≈ $19.15 Million
+162.72%
2019-12-31 €6.23 Million
≈ $7.29 Million
-52.16%
2018-12-31 €13.03 Million
≈ $15.23 Million
+120.66%
2017-12-31 €5.91 Million
≈ $6.90 Million
-43.26%
2016-12-31 €10.41 Million
≈ $12.17 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Check-Cap Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 12292900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Check-Cap Ltd Net Assets Breakdown (December 2025)

Check-Cap Ltd net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Other Components €169.31 Million 4926.01%
Total Equity €3.44 Million 100.00%

Check-Cap Ltd Competitors by Market Cap

The table below lists competitors of Check-Cap Ltd ranked by their market capitalization.

Company Market Cap
Top Shelf International Holdings Ltd
AU:TSI
$9.20 Million
Globe Textiles (India) Limited
NSE:GLOBE
$9.21 Million
Kinovo PLC
LSE:KINO
$9.21 Million
Gold Springs Resource Corp
TO:GRC
$9.22 Million
Inventure Growth & Securities Limited
NSE:INVENTURE
$9.20 Million
TSR Capital Bhd
KLSE:5042
$9.20 Million
Phoenix Motor Inc. Common Stock
NASDAQ:PEV
$9.20 Million
Af Legal Group Ltd
AU:AFL
$9.19 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Check-Cap Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -1,450,000 to 3,437,000, a change of 4,887,000.
  • Net income of 4,140,000 contributed positively to equity growth.
  • Other factors increased equity by 747,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €4.14 Million +120.45%
Other Changes €747.00K +21.73%
Total Change €- %

Book Value vs Market Value Analysis

This analysis compares Check-Cap Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.82x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.38x to 2.82x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €3.68 €1.38 x
2018-12-31 €2.45 €1.38 x
2019-12-31 €0.75 €1.38 x
2020-12-31 €0.35 €1.38 x
2021-12-31 €0.53 €1.38 x
2022-12-31 €7.07 €1.38 x
2023-12-31 €4.05 €1.38 x
2024-12-31 €-0.25 €1.38 x
2025-12-31 €0.49 €1.38 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Check-Cap Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 120.45%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 2.18x
  • Recent ROE (120.45%) is above the historical average (-34.10%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -84.81% 0.00% 0.00x 1.18x €-9.87 Million
2017 165.47% 0.00% 0.00x 1.34x €9.18 Million
2018 -81.27% 0.00% 0.00x 1.18x €-11.89 Million
2019 -221.94% 0.00% 0.00x 1.51x €-14.46 Million
2020 -84.54% 0.00% 0.00x 1.20x €-15.48 Million
2021 -33.94% 0.00% 0.00x 1.10x €-22.27 Million
2022 -46.25% 0.00% 0.00x 1.10x €-23.24 Million
2023 -74.17% 0.00% 0.00x 1.06x €-19.94 Million
2024 0.00% 0.00% 0.00x 0.00x €-25.00 Million
2025 120.45% 0.00% 0.00x 2.18x €3.80 Million

Industry Comparison

This section compares Check-Cap Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $3,714,492,366
  • Average return on equity (ROE) among peers: -73.76%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Check-Cap Ltd (7CC) €3.44 Million -84.81% 1.18x $9.20 Million
IZOTROPIC CORP. (1R3) $-3.85 Million 0.00% 0.00x $6.11 Million
ALPHAHELIX MOL.DIAGN. SK1 (4MB) $637.18K -555.47% 21.05x $839.64K
HANGZHOU TIGERMED CO. H 1 (5HZ1) $24.45 Billion 8.28% 0.21x $601.69 Million
INTERGRATED DIA.H DL 025 (8I8) $3.10 Billion 16.46% 0.86x $251.46 Million
GENETIC ANALYSIS NK -60 (8V8) $32.00 Million -74.44% 0.67x $2.36 Million
GENINCODE PLC LS -01 (9PL) $7.90 Million -70.37% 0.49x $5.28 Million
INOVIQ LTD. (EGQ0) $43.22 Million -28.62% 0.12x $13.00 Million
Eurofins Scientific SE (ESF0) $4.85 Billion 12.58% 1.08x $11.18 Billion
ICON Public Limited Company (IJF) $945.17 Million 27.74% 0.93x $7.52 Billion

About Check-Cap Ltd

F:7CC Germany Diagnostics & Research
Market Cap
$12.47 Million
€10.67 Million EUR
Market Cap Rank
#27152 Global
#2325 in Germany
Share Price
€1.38
Change (1 day)
-8.61%
52-Week Range
€0.82 - €7.80
All Time High
€736.32
About

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.